| Systematic (IUPAC) name | |
|---|---|
| 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 112726-66-6 |
| ATC code | None |
| PubChem | CID 123692 |
| ChemSpider | 110266 |
| ChEMBL | CHEMBL279556 |
| Chemical data | |
| Formula | C19H25NS |
| Mol. mass | 299.474 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Benocyclidine (BCP), or benzothiophenylcyclohexylpiperidine (BTCP), is a psychoactive drug and research chemical of the arylcyclohexylamine class. It acts as a potent and selective dopamine reuptake inhibitor (DRI) and a psychostimulant.[1][2] Unlike related compounds like phencyclidine and ketamine, benocyclidine is a pure DRI with negligible affinity for the NMDA receptor, and it therefore lacks any anticonvulsant, anesthetic, hallucinogenic, or dissociative effects.[1][2] It has been used to label the dopamine transporter.[3][4]
BCP was also used to try to find a common pharmacophore for DRI type stimulants.[5]
More recently, benocyclidine has been found in several ecstasy tablets, sold as MDMA. It is often combined with 5-MeO-DiPT, and is said to be extremely dangerous.[6]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)